Alpha Tau Medical (NASDAQ:DRTS) Posts Quarterly Earnings Results, Hits Expectations

Alpha Tau Medical (NASDAQ:DRTS) posted its quarterly earnings data on Wednesday. The company reported ($0.13) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.13), Zacks reports.

Alpha Tau Medical Stock Performance

Shares of NASDAQ:DRTS traded up $0.06 during trading on Wednesday, reaching $2.66. 18,824 shares of the stock traded hands, compared to its average volume of 48,834. The stock has a market cap of $186.00 million, a P/E ratio of -6.19 and a beta of 0.87. The stock has a 50-day moving average of $3.30 and a two-hundred day moving average of $2.78. Alpha Tau Medical has a 52-week low of $1.75 and a 52-week high of $4.39.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a “buy” rating and set a $9.00 price target on shares of Alpha Tau Medical in a report on Friday, November 22nd.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.